AB 1139 California Assembly · 2013-2014 Regular Session

Prescriptions: biosimilar products.

Summary
The Pharmacy Law governs the practice of pharmacy in this state, including the permissible duties of licensed pharmacists. Among other permitted acts, a pharmacist filling a prescription order for a drug product prescribed by its trade or brand name may select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic drug name as determined by a specified federal entity, of those drug products having the same active chemical ingredients. A person who knowingly violates the Pharmacy Law is guilty of a misdemeanor, as specified. This bill would authorize a pharmacist filling a prescription order for a biological product subject to the Federal Food, Drug, and Cosmetic Act, as specified, to select a biosimilar product, as defined by federal statute, provided that product is deemed by the federal Food and Drug Administration (FDA) to be interchangeable with the prescribed product.
Bill status failed 1 of 4 stages cleared
Introduction
Feb 2013
Committee Review
Floor Vote
Governor
Introduced Feb 22, 2013 Last action Feb 3, 2014
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
7
Key actions
2
Committee
3
Apr 30, 2013
Lower · Passed
In committee: Set, first hearing. Hearing canceled at the request of author.
lower
Mar 14, 2013
Committee
Referred to Coms. on B.,P. & C.P. and HEALTH.
lower
Feb 24, 2013
Lower · Passed
From printer. May be heard in committee March 26.
lower
Feb 22, 2013
Introduced
Introduced. To print.
lower
0 primary · 1 co-sponsor

Sponsors

No sponsor information available.